GOSSAMER BIO, INC.

GOSS ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2021

Total Assets: $343.7M

Liabilities Breakdown FY2021

Total Liabilities: $222.2M